A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Clinical trial NCT06874335 · RECRUITING
Trial details
- NCT number
- NCT06874335
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-20
- Primary completion
- 2029-03-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.